Starmab Biologies Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Series B
- Investors
-
5
Starmab Biologies General Information
Description
Developer of anti-infective macromolecule medicines designed for fungi, bacteria and viruses. The company focuses on antibody drug discovery, pharmaceutical research system and development capabilities, enabling to solve clinical problems that cannot be solved by existing anti-infective drugs.
Contact Information
Corporate Office
- Room 208, Building 2, No. 40, Suhong West Road
- Suzhou Industrial Park
- Suzhou, Jiangsu 215028
- China
Corporate Office
- Room 208, Building 2, No. 40, Suhong West Road
- Suzhou Industrial Park
- Suzhou, Jiangsu 215028
- China
Starmab Biologies Timeline
Starmab Biologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 05-Mar-2025 | Completed | Pre-Clinical Trials | |||
| 1. Early Stage VC (Series A) | 14-Feb-2023 | Completed | Pre-Clinical Trials |
Starmab Biologies Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Wuxi Capital Group | Venture Capital | Minority | ||
| Zhejiang Huahai Pharmaceutical | Corporation | Minority | ||
| Fosun Health Capital | Corporate Venture Capital | Minority | ||
| Suzhou Tahoe Venture Capital | Venture Capital | Minority | ||
| Yaoyou Pharmaceutical | Corporation | Minority |
Starmab Biologies FAQs
-
When was Starmab Biologies founded?
Starmab Biologies was founded in 2020.
-
Where is Starmab Biologies headquartered?
Starmab Biologies is headquartered in Suzhou, China.
-
What industry is Starmab Biologies in?
Starmab Biologies’s primary industry is Drug Discovery.
-
Is Starmab Biologies a private or public company?
Starmab Biologies is a Private company.
-
What is Starmab Biologies’s current revenue?
The current revenue for Starmab Biologies is .
-
How much funding has Starmab Biologies raised over time?
Starmab Biologies has raised $14.7M.
-
Who are Starmab Biologies’s investors?
Wuxi Capital Group, Zhejiang Huahai Pharmaceutical, Fosun Health Capital, Suzhou Tahoe Venture Capital, and Yaoyou Pharmaceutical have invested in Starmab Biologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process